BayMark Health Services Opens New Treatment Center In California’s Central Valley

BayMark Health Services announced the opening of a new outpatient, medication-assisted treatment program in Porterville, California, the fifth BAART Programs location in the Southern Central Valley. BAART Porterville will be focused on offering individualized, quality treatment and support services to those struggling with the disease of opiate addiction.

BAART Programs are known throughout California, and across the country, as providers of methadone and buprenorphine maintenance programs which include counseling with certified professionals as a part of the customized treatment plan for each patient. BAART Programs also provides lab testing, coordinated care for pregnancy and linkages to community resources to assist patients on their path to recovery.

“BayMark is honored to continue to provide these much needed services through our BAART Programs treatment brand,” shared David K. White, Ph.D. CEO of BayMark Health Services. “The need for opioid addiction treatment has unfortunately grown at epidemic rates over the last few years, and in response BayMark Health Services will continue to focus on making evidence-based treatment accessible to those who need it most.”

Medication-assisted treatment has been rigorously studied over more than five decades and is widely considered the most effective way to treat opioid use disorder. For more information on BAART Programs’ MAT services, visit: http://baartprograms.com/.

About BayMark Health Services:

BayMark Health Services, headquartered in Lewisville, Texas, provides medication-assisted treatment for opiate addiction and dependency to thousands of patients nationwide. Our outpatient programs deliver medically supervised treatment, in varied settings and through a variety of modalities, to meet the diverse needs of our patients who struggle with the use of prescription pain medication or other opiates. The BayMark continuum of patient-focused services includes highly structured opioid treatment programs utilizing methadone or buprenorphine and less structured office-based buprenorphine programs, both of which involve counseling as part of an individualized treatment plan. Additional treatment programs consist of ambulatory detoxification services with naltrexone therapy and personalized after care support.